CKMT2 and Parkinson disease: However, we have yet to find a study that explicitly focuses on the study of MtCK in clinical PD patients, and only several studies have investigated the serum CK levels of PD patients [14] and the CK-B activity of PD, idiopathic epilepsy, multiple sclerosis patients, etc.[15]